<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04604717</url>
  </required_header>
  <id_info>
    <org_study_id>110314</org_study_id>
    <secondary_id>IBAS110314</secondary_id>
    <nct_id>NCT04604717</nct_id>
  </id_info>
  <brief_title>Effect of Exercise Training on Salivary Immunoglobulin A in Patients With Chronic Obstructive Pulmonary Disease</brief_title>
  <official_title>Effect of Exercise Training on Salivary Immunoglobulin A in Patients With Chronic Obstructive Pulmonary Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bayside Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Austin Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Newcastle University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Bayside Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether whole body exercise training alters the&#xD;
      immunity in the lungs of people with COPD and reduces the incidence of chest infections over&#xD;
      the longer term.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will undertake an 8 weeks pulmonary rehabilitation program of exercise and&#xD;
      education. Those who decline to take part in pulmonary rehabilitation will have the same&#xD;
      outcome measures collected at the same timepoints.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Actual">June 30, 2017</completion_date>
  <primary_completion_date type="Actual">June 30, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Salivary Immunoglobulin A levels</measure>
    <time_frame>Change over 8 weeks</time_frame>
    <description>SIgA</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in circulatory inflammatory markers</measure>
    <time_frame>Change over 8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in physical activity levels</measure>
    <time_frame>Change over 8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health status</measure>
    <time_frame>Change over 8 weeks</time_frame>
    <description>COPD assessment test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exercise capacity (6MWT)</measure>
    <time_frame>Change over 8 weeks</time_frame>
    <description>Distance walked in 6 minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of acute exacerbations</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">35</enrollment>
  <condition>COPD</condition>
  <arm_group>
    <arm_group_label>Pulmonary rehabilitation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>8 weeks of pulmonary rehabilitation (twice weekly training) Exercise and education sessions accompanied by home exercise program</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual medical treatment for 8 week period</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Pulmonary rehabilitation</intervention_name>
    <description>8 weeks of exercise training (twice weekly) of education and exercise</description>
    <arm_group_label>Pulmonary rehabilitation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of COPD (FEV1/FVC &lt; 70), smoking Hx of minimum of 10 pack years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of asthma, bronchiectasis, attendance at pulmonary rehabilitation within&#xD;
             last 12 months, exacerbation of COPD within last 4 weeks&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anne Holland, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Alfred Health, La Trobe University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Alfred Health</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3004</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Austin Health</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3084</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>March 11, 2014</study_first_submitted>
  <study_first_submitted_qc>October 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 27, 2020</study_first_posted>
  <last_update_submitted>October 21, 2020</last_update_submitted>
  <last_update_submitted_qc>October 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>COPD,</keyword>
  <keyword>Pulmonary rehabilitation,</keyword>
  <keyword>Airway immunity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

